Literature DB >> 12181216

Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction.

A Varela-Roman1, J R Gonzalez-Juanatey, P Basante, R Trillo, J Garcia-Seara, J L Martinez-Sande, F Gude.   

Abstract

OBJECTIVE: To determine the clinical and prognostic differences between patients with heart failure who had preserved or deteriorated systolic function, defined as a left ventricular ejection fraction of > 50% or < 50%, respectively, within two weeks of admission to hospital.
METHODS: The records of 229 patients with congestive heart failure were studied. There were 95 women and 134 men, mean (SD) age 66.7 (11.7) years, who had been admitted to a cardiology department for congestive heart failure in the period 1991 to 1994, and whose left ventricular systolic function had been evaluated echocardiographically within two weeks of admission. Data were collected on the main clinical findings, supplementary investigations, treatment, and duration of hospital admission. Follow up information was obtained in the spring of 1998 by searching the general archives of the hospital and by a telephone survey.
RESULTS: Left ventricular systolic function was preserved in 29% of the patients. The preserved and deteriorated groups differed significantly in the sex ratio (more women in the preserved group) and in the presence of a third heart sound, cardiomegaly, alveolar oedema, ischaemic cardiomyopathy, and treatment with angiotensin converting enzyme (ACE) inhibitors (all more in the deteriorated group). There were no significant differences in age, New York Heart Association functional class, rhythm disturbances, left ventricular hypertrophy, treatment with drugs other than ACE inhibitors, or survival. In the group as a whole, the survival rates after three months, one year, and five years were 92.6%, 80%, and 48.4%, respectively.
CONCLUSIONS: In view of the unexpectedly poor prognosis of patients with congestive heart failure and preserved left ventricular systolic function, controlled clinical trials should be carried out to optimise their treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12181216      PMCID: PMC1767326          DOI: 10.1136/heart.88.3.249

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

Review 1.  Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults.

Authors:  M W Rich
Journal:  J Am Geriatr Soc       Date:  1997-08       Impact factor: 5.562

2.  Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance.

Authors:  J F Setaro; R Soufer; M S Remetz; R A Perlmutter; B L Zaret
Journal:  Am J Cardiol       Date:  1992-05-01       Impact factor: 2.778

3.  Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study.

Authors:  M Kupari; M Lindroos; A M Iivanainen; J Heikkilä; R Tilvis
Journal:  J Intern Med       Date:  1997-05       Impact factor: 8.989

4.  The progression from hypertension to congestive heart failure.

Authors:  D Levy; M G Larson; R S Vasan; W B Kannel; K K Ho
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

5.  Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group.

Authors:  J N Cohn; G Johnson
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

6.  Relation between gender, etiology and survival in patients with symptomatic heart failure.

Authors:  K F Adams; S H Dunlap; C A Sueta; S W Clarke; J H Patterson; M B Blauwet; L R Jensen; L Tomasko; G Koch
Journal:  J Am Coll Cardiol       Date:  1996-12       Impact factor: 24.094

7.  Trends in hospitalization and mortality for heart failure in Spain, 1980-1993.

Authors:  F Rodríguez-Artalejo; P Guallar-Castillón; J R Banegas Banegas; J del Rey Calero
Journal:  Eur Heart J       Date:  1997-11       Impact factor: 29.983

Review 8.  Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective.

Authors:  R S Vasan; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1995-12       Impact factor: 24.094

9.  Survival after the onset of congestive heart failure in Framingham Heart Study subjects.

Authors:  K K Ho; K M Anderson; W B Kannel; W Grossman; D Levy
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

10.  Hypertensive hypertrophic cardiomyopathy of the elderly.

Authors:  E J Topol; T A Traill; N J Fortuin
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

View more
  16 in total

1.  Congestion is the driving force behind heart failure.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2012-09

2.  Heart failure in patients with preserved and deteriorated left ventricular ejection fraction.

Authors:  A Varela-Roman; L Grigorian; E Barge; P Bassante; M G de la Peña; J R Gonzalez-Juanatey
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

3.  Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure.

Authors:  Ali Ahmed
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-10       Impact factor: 6.053

4.  Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.

Authors:  N M Hawkins; D Wang; J J V McMurray; M A Pfeffer; K Swedberg; C B Granger; S Yusuf; S J Pocock; J Ostergren; E L Michelson; F G Dunn
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

5.  Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction.

Authors:  Ali Ahmed; Inmaculada B Aban; Michael T Weaver; Wilbert S Aronow; Jerome L Fleg
Journal:  Eur J Heart Fail       Date:  2005-11-28       Impact factor: 15.534

Review 6.  Drug therapy in chronic heart failure.

Authors:  D B McKenzie; A J Cowley
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

7.  Diuretics as pathogenetic treatment for heart failure.

Authors:  Maya Guglin
Journal:  Int J Gen Med       Date:  2011-01-23

8.  Key role of congestion in natural history of heart failure.

Authors:  Maya Guglin
Journal:  Int J Gen Med       Date:  2011-08-15

9.  Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.

Authors:  Markus Noveanu; Tobias Breidthardt; Mihael Potocki; Tobias Reichlin; Raphael Twerenbold; Heiko Uthoff; Thenral Socrates; Nisha Arenja; Miriam Reiter; Julia Meissner; Corinna Heinisch; Sybille Stalder; Christian Mueller
Journal:  Crit Care       Date:  2011-01-05       Impact factor: 9.097

10.  Characterisation of heart failure with normal ejection fraction in a tertiary hospital in Nigeria.

Authors:  Adedeji K Adebayo; Adewole A Adebiyi; Olulola O Oladapo; Okechukwu S Ogah; Akinyemi Aje; Dike B Ojji; Ayodele O Falase
Journal:  BMC Cardiovasc Disord       Date:  2009-11-18       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.